The US blood supply is extraordinarily safe due to the vigilance of many stakeholders, not the least of which is the Blood Products Advisory Committee of the FDA. As the healthcare community moves headlong into a new generation of human-derived products, including stem cells and other harvestable elements from blood or serum, the contribution of this Committee continues to loom large for the nation.
Methods for detecting emerging pathogens and the safe manufacture of diagnostics and replacement therapies have been the focus of the BPAC in recent years. Effective presentation and discussion of issues at this Committee's meetings are key to continuing the stellar track record of blood product safety in the US.
Please contact us via email or at +1-201-894-8200 to discuss your needs or to get further information about how we can support your upcoming BPAC meeting.
